XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health Careers World General

 
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
  Anaemia
   Darbepoetin Alfa
   Deferasirox
  Hemophilia
  Polycythemia
  Thalassemias
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate
Search
Exams
  gre
  ielts
  mrcgp
  mrcgp books
  mrcog
  mrcog books
  mrcp
  mrcp books
  mrcpath
  mrcpch
  mrcpch books
  mrcpsych
  mrcs
  mrcs books
  plab
  usmle

Subject Forums
  Anaesthesia
  Anatomy
  Biochemistry
  Biophysics
  Biostatistics
  Cardiology
  Dermatology
  Embryology
  Endocrinology
  ENT
  Forensic Medicine
  Gastroenterology
  Genetics
  Gynaecology-Obstetrics
  Haematology
  Medicine
  Microbiology
  Nephrology
  Neurology
  Ophthalmology
  Orthopaedics
  Paediatrics
  Parasitology
  Pathology
  Pharmacology
  Physiology
  Preventive Medicine
  Psychiatry
  Radiology
  Respiratory Medicine
  Rheumatology
  Toxicology
  Surgery

Latest Research : Haematology : Anaemia Last Updated: Nov 18, 2006 - 1:55:25 PM

Latest Research : Haematology : Anaemia : Deferasirox
Deferasirox may revolutionize the way chronic iron overload is treated
Those with severe chronic anemias need frequent blood transfusions to remain healthy, but such frequent transfusions can cause a potentially deadly buildup of iron in the body, leading to heart and liver failure. The traditional treatment to remove excess iron is so onerous that many patients choose to forgo it, putting their own lives at risk. The results of an international study on deferasirox, a new drug that may revolutionize the way chronic iron overload is treated, will be published in the May 1, 2006, issue of Blood, the official journal of the American Society of Hematology.
Apr 23, 2006 - 6:23:00 PM

[ Visit Website ] Latest Research : Haematology : Anaemia : Darbepoetin Alfa
FDA approves extended dosing of Aranesp
Amgen (NASDAQ: AMGN), the world's largest biotechnology company, today announced the U.S. Food and Drug Administration (FDA) has approved every-three-week dosing of Aranesp� (darbepoetin alfa) for the treatment of chemotherapy-induced anemia (low red blood cell count) in patients with non-myeloid malignancies. Aranesp is the only erythropoiesis-stimulating agent approved by the FDA for every-three-week administration.
Mar 28, 2006 - 7:59:00 PM

[ Visit Website ] Latest Research : Haematology : Anaemia : Darbepoetin Alfa
Study Suggests Drug For Chemotherapy-Induced Anemia Can Be Effectively Administered Tri-Weekly
Parallel administration of chemotherapy and an anti-anemia drug called darbepoetin alfa every 3 weeks is safe and effective, according to a new study.
Feb 15, 2006 - 8:01:00 PM

[ Visit Website ] Latest Research : Haematology : Anaemia
Aranesp treatment achieved and maintained target hemoglobin levels and reduced incidence of red blood cell transfusions
Amgen (NASDAQ: AMGN), the world's largest biotechnology company, today announced interim results from the first multi-center, randomized, double-blind, placebo-controlled, Phase 3 trial of Aranesp� (darbepoetin alfa) administered every three weeks in cancer patients with chemotherapy-induced anemia. The study revealed that Aranesp increased and maintained patient hemoglobin levels to the target level of greater than or equal to 11 grams per deciliter (g/dL) and reduced the need for red blood cell transfusions by almost half compared to placebo. The data were presented at the American Society of Hematology (ASH) 47th Annual Meeting and Exposition. (Abstract #3556)
Dec 14, 2005 - 8:09:00 PM

[ Visit Website ] Latest Research : Haematology : Anaemia : Darbepoetin Alfa
Interim Aranesp data suggest major response in anemic patients with MDS
Amgen (NASDAQ: AMGN), the world's largest biotechnology company, today announced updated interim data from a Phase 2 study evaluating the use of 500 mcg of Aranesp darbepoetin alfa) administered every three weeks to treat anemia in patients with a bone marrow disorder known as myelodysplastic syndrome (MDS). Low-risk MDS patients receiving Aranesp every three weeks, who had no prior erythropoietic therapy, exhibited an overall response of 70 percent, increased hemoglobin levels and improvements in patient-reported fatigue.
Dec 13, 2005 - 8:06:00 PM

[ Visit Website ] Latest Research : Haematology : Anaemia : Darbepoetin Alfa
Interim data suggest major response with Aranesp(R) in anemic patients with MDS
Amgen Inc. (NASDAQ:AMGN), the world's largest biotechnology company, today announced new interim data from a Phase 2 study evaluating the use of 500 mcg of Aranesp(R) (darbepoetin alfa) every three weeks to treat anemia in patients with a bone marrow disorder known as myelodysplastic syndromes (MDS). The data were presented at the 17th International Symposium of the Multinational Association of Supportive Care in Cancer (MASCC) in Geneva. (Abstract #02-007)
Jul 10, 2005 - 8:17:00 PM

[ Visit Website ] Latest Research : Haematology : Anaemia : Darbepoetin Alfa
Aranesp dosed every three weeks achieved and maintained target hemoglobin levels
Amgen Inc., (NASDAQ: AMGN) the world's largest biotechnology company, today announced that new interim data from a single-arm, open label study of 1,225 cancer patients receiving chemotherapy demonstrated that Aranesp� (darbepoetin alfa) administered every three weeks was effective in increasing and maintaining patient hemoglobin levels to the recommended target of greater than or equal to 11 g/dL. Further, treatment with Aranesp reduced the need for red blood cell transfusions in cancer patients with chemotherapy-induced anemia.
May 16, 2005 - 8:27:00 PM

[ Visit Website ] Latest Research : Haematology : Anaemia : Darbepoetin Alfa
Final results demonstrate Aranesp dosed every two weeks is comparable to Epoetin alfa dosed weekly
Amgen Inc., (NASDAQ: AMGN) the world's largest biotechnology company, today announced that final results of a Phase 3 randomized, head-to-head study demonstrated that 200 mcg of Aranesp� (darbepoetin alfa) administered every two weeks is as effective as 40,000 U of Epoetin alfa dosed once a week in boosting hemoglobin levels and reducing the need for red blood cell transfusions in cancer patients with chemotherapy-induced anemia.
May 16, 2005 - 8:23:00 PM

[ Visit Website ] Latest Research : Haematology : Anaemia : Darbepoetin Alfa
Anemia drug reduces transfusions and chemotherapy-related fatigue
Patients treated with darbepoetin alfa (AranespTM) for chemotherapy-induced anemia may require fewer blood transfusions and feel less fatigued than patients receiving a placebo, concludes a new study in the August 21 issue of the Journal of the National Cancer Institute.
Aug 28, 2002 - 8:15:00 PM

[ Visit Website ]
<< prev next >>

Headlines
Health  
Gathering information about food is not top priority for individuals with high metabolisms
NIH renews funding for University of Maryland vaccine research
DHA-enriched formula in infancy linked to positive cognitive outcomes in childhood
New IOM report lays out plan to determine effectiveness of obesity prevention efforts
Vitamin D supplementation may delay precocious puberty in girls
Study: Pedometer program helps motivate participants to sit less, move more
Fish oil may stall effects of junk food on brain
Intake of low energy dense food better than skipping meals
Inaugural IOF Olof Johnell Science Award presented to Professor Harry Genant
Molecular hub links obesity, heart disease to high blood pressure
Healthcare  
Healthcare experts from UK and India meet at the UK Parliament to discuss ways to improve health care in India, UK
Flu pandemic infected one in five
Stigma preventing leprosy-cured from getting jobs
Measles, Mumps make a comeback in US
Melinda Gates calls on Akhilesh Yadav
'Movies, TV impact tobacco users more than newspapers'
Rockland to open three new hospitals in NCR
Spice Global enters healthcare business with hospital in Delhi
Delhi to expedite recruitment of doctors
India adds spice to US life, keeps it healthy
Latest Research  
How do consumers see a product when they hear music?
Drug activates virus against cancer
Bone loss associated with increased production of ROS
Sound preconditioning prevents ototoxic drug-induced hearing loss in mice
Crystal methamphetamine use by street youth increases risk of injecting drugs
Johns Hopkins-led study shows increased life expectancy among family caregivers
Moderate to severe psoriasis linked to chronic kidney disease, say experts
Licensing deal marks coming of age for University of Washington, University of Alabama-Birmingham
Simple blood or urine test to identify blinding disease
Physician job satisfaction driven by quality of patient care
Medical News  
NHRC issues notice to Kerala over infant deaths
Advanced breast cancer detecting machine comes to India
'Dispel myths about vitiligo'
NHRC summons Odisha chief secretary
Woman dies of swine flu in UP
Maharashtra, GE to modernise rural health care
Hypertension: India's silent killer
Need cautious effort to eradicate polio: Experts
Ayurveda experts develop online personalised health regimen
Soon a detailed study on 'diabesity': Doctors
Special Topics  
MPs express anguish at Delhi gang-rape, Shinde assures fast trial
Worrying rise in number of medical students in prostitution over last 10 years
Behold India's unfolding democratic revolution
Chinese woman cuts open her belly to save surgery cost
Improved Sense of Smell Produced Smarter Mammals
Two-year-old world's first to have extra DNA strand
172,155 kidney stones removed from one patient!
'Primodial Soup' theory for origin of life rejected in paper
Human species could have killed Neanderthal man
History, geography also seem to shape our genome

Chief Medical Editor: Dr Sanjukta Acharya; Managing Editor & Founder: Dr Himanshu Tyagi; Editors: Dr Rashmi Yadav, Dr Ankush Vidyarthi; Chief Correspondent: Dr Priya Saxena
© Copyright 2004 by rxpgnews.com
Contact Us